Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adenovirus Carrying Hepatocyte Growth Factor (Ad-HGF) Treatment for Myocardial Infarction
NCT02844283Phase 2Unknown
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Nov 2016
- Primary completion
- Jul 2018
- Modality
- Gene Editing, Gene Silencing, Viral Vectors
01
Overview
A Phase 2 trial of adenovirus-hepatocyte growth factor in myocardial infarction (MI), sponsored by Jiangsu Provincial People's Hospital. Status: unknown.
02
Drugs
adenovirus-hepatocyte growth factor
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT02844283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02844283.